Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin?

Sawdy, 1997, Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery, Lancet, 350, 265, 10.1016/S0140-6736(05)62229-5 Poore, 1999, Efficacy of the selective prostaglandin synthase type 2 inhibitor nimesulide in blocking basal prostaglandin production and delaying glucocorticoid-induced premature labor in sheep, Am J Obstet Gynecol, 180, 1244, 10.1016/S0002-9378(99)70624-1 Hawkey, 1999, COX-2 inhibitors, Lancet, 353, 307, 10.1016/S0140-6736(98)12154-2 Peruzzi, 1999, Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic, Lancet, 354, 1615, 10.1016/S0140-6736(99)03105-0 Balasubramaniam, 2000, Nimesulide and neonatal renal failure, Lancet, 355, 575, 10.1016/S0140-6736(05)73223-2